Roles of PI 3-kinase isoforms in autophagy and endosomal membrane dynamics
Roles of PI 3-kinase isoforms in autophagy and endosomal membrane dynamics
批准号:
G0700755/1
负责人:
Bart Vanhaesebroeck
金额:
$47.05万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
One of the most fundamental component parts of the human body is a structure termed a cell. Every cell is surrounded by a membrane of fat which maintains its identity separate from the surrounding environment. Furthermore, every cell is subdivided into more compartments by itself containing discrete and unique membrane-bound structures termed organelles. In order for a cell to function it must be able to perform a number of roles including communication with the extracellular milieu, the regulated transfer of material between organelles and the recycling of aged material within the cell itself. Defects in any of these functions can lead to abberations which ultimately cause the cell to malfunction and lead to cancer, the unregulated growth of cells. Our laboratory works on catalysts within the cell termed PI3Ks. PI3Ks are able to specifically manipulate the composition of the cellular membranes. These manipulations are critical to ensure fidelity of the transfer of material between organelles and between the external environment and organelles. The importance of these PI3Ks in maintaining normal cellular functions is highlighted by the fact that they are compromised in a high percentage of tumors. Consequently it is obvious that if we wish to tackle the causes of cancer and try to cure patients suffering from cancer it is vital that we know how PI3Ks function in whole organisms. The main problem with this avenue of enquiry however is that there are numerous flavors of PI3K within cells and each performs a distinct role within the cell. To this end our laboratory generate mice models where the activity of discrete PI3Ks are specifically ablated, both at the level of cells and the whole organism. By this methodology we are able to assign specific roles to each PI3K and in combination with drug companies design small molecule inhibitors targeted towards each PI3K. These small molecule inhibitors are then tested in directed experiments to see whether they will be of any therapeutic use in tackling cancer and other health issues arising from defective PI3K signalling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integration of lipid and protein kinase signalling in primary cilia biology
-
批准号:BB/W007460/1
-
项目类别:Research Grant
-
资助金额:$60.23万
-
财政年份:2022
-
负责人:Bart Vanhaesebroeck
-
依托单位:
Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
-
批准号:MC_PC_MR/S02607X/1
-
项目类别:Research Grant
-
资助金额:$7.55万
-
财政年份:2019
-
负责人:Bart Vanhaesebroeck
-
依托单位:
Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation
-
批准号:BB/R017972/1
-
项目类别:Research Grant
-
资助金额:$56.47万
-
财政年份:2018
-
负责人:Bart Vanhaesebroeck
-
依托单位:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
-
批准号:BB/M013278/1
-
项目类别:Research Grant
-
资助金额:$15.7万
-
财政年份:2016
-
负责人:Bart Vanhaesebroeck
-
依托单位:
Revised Milestone 1 for Grant Reference BB/M013278/1
-
批准号:BB/N013522/1
-
项目类别:Research Grant
-
资助金额:$5.05万
-
财政年份:2015
-
负责人:Bart Vanhaesebroeck
-
依托单位:
Signalling and biological roles of the class II and III PI 3-kinase enzymes
-
批准号:BB/I007806/2
-
项目类别:Research Grant
-
资助金额:$26.62万
-
财政年份:2014
-
负责人:Bart Vanhaesebroeck
-
依托单位:
Signalling and biological roles of the class II and III PI 3-kinase enzymes
-
批准号:BB/I007806/1
-
项目类别:Research Grant
-
资助金额:$148.04万
-
财政年份:2011
-
负责人:Bart Vanhaesebroeck
-
依托单位:
The role of PI 3-kinase/AKT/mTOR and interacting pathways in haematological cancers
-
批准号:G0800914/1
-
项目类别:Research Grant
-
资助金额:$56.76万
-
财政年份:2008
-
负责人:Bart Vanhaesebroeck
-
依托单位:
PI 3-kinase isoform-specific-signalling in macrophages.
-
批准号:BB/C505659/2
-
项目类别:Research Grant
-
资助金额:$4.22万
-
财政年份:2007
-
负责人:Bart Vanhaesebroeck
-
依托单位:
国内基金
海外基金
登录
查看更多内容
第452位络氨酸磷酸化PI3Kp85抗体的制备方法和使用方法
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:迟寅秀
-
依托单位:
NCAPD2通过PI3K-AKT-mTOR-Myc信号轴促进子宫内膜样癌增殖及EMT的机制与靶向治疗研究
-
批准号:JCZRLH202600400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“痞积转化”理论探究网果酸模通过PI3K/Akt通路调控巨噬细胞极化平衡抑制胃癌的分子机制
-
批准号:JCZRLH202601927
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
“补肾健脾,化痰通络”法调控PI3K/Akt/MCT1介导的乳酸转运改善血管性痴呆的机制研究
-
批准号:JCZRLH202600974
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
葛根素通过调控PI3K/Akt介导的代谢重编程抑制心肌梗死后心脏纤维化的机制研究
-
批准号:2026JJ80327
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张婷
-
依托单位:
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
基于PI3K/Akt信号通路探索气道炎症在慢性阻塞性肺疾病中的作用及培元固肺膏干预研究
-
批准号:2026JJ82022
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘丹
-
依托单位:
LINC00152通过PI3K-AKT信号通路与NRF2/GPX4铁死亡调控网络促进睾丸生殖细胞肿瘤进展的机制研究
-
批准号:2026JJ82173
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘志中
-
依托单位:
基于PI3K/Akt信号通路探讨钩大青酮调控BGN-COL1A1轴抑制结肠癌侵袭与迁移的机制研究
-
批准号:2026JJ82464
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陆文洪
-
依托单位:
成纤维细胞中NR2F1-AS1协同KRAS通过PI3K/AKT/mTOR途径促进胰腺导管腺癌发展
-
批准号:2026JJ82537
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周小兵
-
依托单位: